Prognostic significance of smac/DIABLO in endometrioid endometrial cancer

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer

Show other versions (1)

Apoptosis may occur via a death receptor-dependent or independent (mitochondrial) pathway. The mitochondrialpathway is regulated by small molecules, such as smac/Diablo, which activates caspase cascades. This study examinedsmac/DIABLO expression in 76 patients with endometrioid endometrial cancers....

Full description

Bibliographic Details
Main Authors:	Bozena Dobrzycka, Slawomir J. Terlikowski, Piotr S. Bernaczyk, Magdalena Garbowicz, Jacek Niklinski, Lech Chyczewski, Marek Kulikowski
Format:	Article
Language:	English
Published:	Via Medica 2010-04-01
Series:	Folia Histochemica et Cytobiologica
Subjects:	endometrioid endometrial cancer smac/DIABLO prognosis
Online Access:	http://www.fhc.viamedica.pl/darmowy_pdf.phtml?indeks=128&indeks_art=1292

Similar Items

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
by: Magdalena Garbowicz, et al.
Published: (2011-04-01)

Is there something else besides the proapoptotic AVPI-segment in the Smac/DIABLO protein?
by: Georgina Victoria-Acosta, et al.
Published: (2016-11-01)

Future Therapeutic Directions for Smac-Mimetics
by: Emma Morrish, et al.
Published: (2020-02-01)

Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein
by: Rossella De Marco, et al.
Published: (2020-06-01)

The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein
by: Raffaela Mariarosaria Mariniello, et al.
Published: (2020-01-01)

The prognostic significance of the immunohistochemical expression of P53 and BCL-2 in endometrial cancer
by: Lech Chyczewski, et al.
Published: (2012-01-01)

Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
by: Xiao-Yun Zhao, et al.
Published: (2020-04-01)

An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment
by: Yung-Chieh Chang, et al.
Published: (2021-12-01)

Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers
by: Lenka Kalinkova, et al.
Published: (2020-08-01)

Microsatellite Instability in Young Women with Endometrioid type Endometrial Cancer
by: MR Abbaszadegan, et al.
Published: (2009-09-01)

Microsatellite Instability in Young Women with Endometrioid type Endometrial Cancer
by: MR Abbaszadegan, et al.
Published: (2009-09-01)

Prognostic parameters in FIGO stage I endometrial carcinoma of endometrioid type
by: Stanojević Zorica, et al.
Published: (2006-01-01)

Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary
by: Shuang-zheng Jia, et al.
Published: (2018-04-01)

Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation
by: Cigdem Ussakli, et al.
Published: (2016-11-01)

Can Magnetic Resonance Imaging Predict Pathologic Findings for Endometrioid Endometrial Cancer?
by: Elizabeth L. Dickson Michelson, et al.
Published: (2020-04-01)

Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare, often unrecognized collision tumor
by: Grace Kim, et al.
Published: (2015-08-01)

Unique prognostic features of grade 3 endometrioid endometrial carcinoma: Findings from 101 consecutive cases at a Japanese tertiary cancer center
by: Mayumi Kobayashi Kato, et al.
Published: (2021-03-01)

Genomic Comparison of Endometrioid Endometrial Carcinoma and Its Precancerous Lesions in Chinese Patients by High-Depth Next Generation Sequencing
by: Yao Wang, et al.
Published: (2019-03-01)

Diagnostic performance of intraoperative assessment in grade 2 endometrioid endometrial carcinoma
by: Antonio Bandala-Jacques, et al.
Published: (2020-10-01)

Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
by: Menghan Zhu, et al.
Published: (2017-10-01)

The extent of cyclin D1 expression in endometrial pathologies and relevance of cyclin D1 with the clinicopathological features of endometrioid endometrial carcinoma
by: Hulya Tosun Yildirim, et al.
Published: (2020-01-01)

Quality of life in long-term survivors of early stage endometrial cancer
by: Bożena Dobrzycka, et al.
Published: (2017-09-01)

Development of localized cul-de-sac endometrioid carcinoma associated with deep infiltrating endometriosis during remission of early endometrial cancer
by: Kumiko Seki, et al.
Published: (2020-02-01)

The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
by: Zhao Liu, et al.
Published: (2021-02-01)

Induction and redistribution of XAF1, a new antagonist of XIAP in the rat brain after transient focal ischemia
by: M. Siegelin, et al.
Published: (2005-11-01)

Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma
by: Sujin Park, et al.
Published: (2021-08-01)

What is the impact of radical hysterectomy on endometrial cancer with cervical involvement?
by: Salim Abraham Barquet-Muñoz, et al.
Published: (2020-05-01)

High Expression of Galectin-1, VEGF and Increased Microvessel Density Are Associated with MELF Pattern in Stage I-III Endometrioid Endometrial Adenocarcinoma
by: Dmitry Aleksandrovich Zinovkin, et al.
Published: (2019-09-01)

YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia/ intraepithelial neoplasia
by: Bian, P.-P, et al.
Published: (2022)

ROS mediate selenite-induced apoptosis in colon cancer cells
by: Králová Věra, et al.
Published: (2010-04-01)

Dedifferentiated endometrioid adenocarcinoma of the uterus: A case series and review of literature
by: C. Goh, et al.
Published: (2020-05-01)

Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report
by: Mitsutake Yano, et al.
Published: (2019-06-01)

Low Red Blood Cell Count as an Early Indicator for Myometrial Invasion in Women with Endometrioid Endometrial Carcinoma with Metabolic Syndrome
by: Tong Y, et al.
Published: (2020-10-01)

Long-term survival of a patient with stage IIIC2 grade 3 endometrioid endometrial carcinoma treated with surgery alone
by: Isao Otsuka, et al.
Published: (2021-11-01)

Infección por el virus de la Lengua azul: activación de señales celulares que inducen apoptosis Bluetongue virus infection: signaling pathway activated during apoptosis
by: E. Mortola, et al.
Published: (2009-09-01)

Screening and Identification of Prognostic Tumor-Infiltrating Immune Cells and Genes of Endometrioid Endometrial Adenocarcinoma: Based on The Cancer Genome Atlas Database and Bioinformatics
by: Bingnan Chen, et al.
Published: (2020-12-01)

Comparison of Different Lymph Node Staging Schemes for Predicting Survival Outcomes in Node-Positive Endometrioid Endometrial Cancer Patients
by: Xi-Lin Yang, et al.
Published: (2021-07-01)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
by: Mei Yu, et al.
Published: (2020-08-01)

Immunohistochemical expression of PTEN in normal, hyperplastic and endometrial carcinoma of endometrium
by: IzadiMood, et al.
Published: (2008-08-01)

Case Report: Double Germline Mutations in BRCA1 and MSH2 in a Patient With Mixed Serous-Endometrioid Endometrial Carcinoma
by: Hong Zheng, et al.
Published: (2020-11-01)